Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis

Molecular and Cellular Proteomics

Volumn 6, Issue 10, 2007, Pages 1798-1808

  Sun, Wei ^a   Xing, Baocai ^b   Sun, Yi ^b   Du, Xiaojuan ^c   Lu, Min ^c   Hao, Chunyi ^b   Lu, Zhuang ^a   Mi, Wei ^a   Wu, Songfeng ^a   Wei, Handong ^a   Gao, Xue ^a   Zhu, Yunping ^a   Jiang, Ying ^a   Qian, Xiaohong ^a   He, Fuchu ^a,d  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GENE PRODUCT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MITOCHONDRIAL PROTEIN; PROTEOME; S ADENOSYLMETHIONINE; TUMOR MARKER;

ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PEROXISOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FAMILY; PROTEIN PROCESSING; RISK ASSESSMENT; RISK FACTOR; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; AMMONIA-LYASES; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEOME; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBCELLULAR FRACTIONS; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS B VIRUS;

EID: 35648963627     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M600449-MCP200     Document Type: Article

References (68)

1. Van den Bergh, G., and Arckens, L. (2004) Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr. Opin. Biotechnol. 15, 38-43
2. Yan, J. X., Devenish, A. T., Wait, R., Stone, T., Lewis, S., and Fowler, S. (2002) Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics 2, 1682-1698
3. Kolkman, A., Dirksen, E. H., Slijper, M., and Heck, A. J. (2005) Double standards in quantitative proteomics: direct comparative assessment of difference in gel electrophoresis and metabolic stable isotope labeling. Mol. Cell. Proteomics 4, 255-266
4. Zhou, G., Li, H., DeCamp, D., Chen, S., Shu, H., Gong, Y., Flaig, M., Gillespie, J. W., Hu, N., Taylor, P. R., Emmert-Buck, M. R., Liotta, L. A. Petricoin, E. F., III, and Zhao, Y. (2002) 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell. Proteomics 1, 117-124
5. Friedman, D. B., Hill, S., Keller, J. W., Merchant, N. B., Levy, S. E., Coffey, R. J., and Caprioli, R. M. (2004) Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4, 793-811
6. Anazawa, Y., Nakagawa, H., Furihara, M., Ashida, S., Tamura, K., Yoshioka, H., Shuin, T., Fujioka, T., Katagiri, T., and Nakamura, Y. (2005) PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Iβ/SET. Cancer Res. 65, 4578-4586
7. Yu, K. H., Rustgi, A. K., and Blair, I. A. (2005) Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J. Proteome Res. 4, 1742-1751
8. Cha, C., DeMatteo, R. P., and Blumgart, L. H. (2002) Surgery and ablative therapy for hepatocellular carcinoma. J. Clin. Gastroenterol. 35, S130-S137
9. Tang, Z. Y. (2001) Hepatocellular carcinoma-cause, treatment and metastasis. World J. Gastroenterol. 7, 445-454
10. Lim, S. O., Park, S.J., Kim, W., Park, S. G., Kim, H. J., Kim, Y. I., Sohn,T. S., Noh, J. H., and Jung, G. (2002) Proteome analysis of hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 291, 1031-1037
11. Kim, W., Oe Lim, S., Kim, J. S., Ryu, Y. H., Byeon, J. Y., Kim, H. J., Kim, Y. I., Heo, J. S., Park, Y. M., and Jung, G. (2003) Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clin. Cancer Res. 9, 5493-5500
12. Li, C., Hong, Y., Tan, Y. X., Zhou, H., Ai, J. H. Li, S. J., Zhang, L., Xia, Q. C., Wu, J. R., Wang, H. Y., and Zeng, R. (2004) Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol. Cell. Proteomics 3, 399-409
13. Li, C., Tan, Y. X., Zhou, H., Ding, S. J., Li, S. J., Ma, D. J., Man, X. B., Hong, Y., Zhang, L., Li, L., Xia, Q. C., Wu, J. R., Wang, H. Y., and Zeng, R. (2005) Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: identification of potential tumor markers. Proteomics 5, 1125-1139
14. Liang, C. R., Leow, C. K., Neo, J. C., Tan, G. S., Lo, S. L., Lim, J. W., Seow, T. K., Lai, P. B., and Chung, M. C. (2005) Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 5, 2258-2271
15. Kim, J., Kim, S. H., Lee, S. U., He, G. H., Kang, D. G., Ha, N. Y., Ahn, J. S., Cho, H. Y., Kang, S. J., Lee, Y. J., Hong, S. C., Ha, W. S., Bae, J. M., Lee, C. W., and Kim, J. W. (2002) Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 23, 4142-4156
16. Park, K. S., Kim, H., Kim, N. G., Cho, S. Y., Choi, K. H., Seong, J. K., and Paik, Y. K. (2002) Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. Hepatology 35, 1459-1466
17. Park, K. S., Cho, S. Y., Kim, H., and Paik, Y. K. (2002) Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int. J. Cancer 97, 261-265
18. Luk, J. M., Lam, C. T., Siu, A. F., Lam, B. Y., Ng, I. O., Hu, M. Y., Che, C. M., and Fan, S. T. (2006) Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 6, 1049-1057
19. Lee, I. N., Chen, C. H., Sheu, J. C., Lee, H. S., Huang, G. T., Yu, C. Y., Lu, F. J., and Chow, L. P. (2005) Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J. Proteome Res. 4, 2062-2069
20. Melle, C., Kaufmann, R., Hommann, M., Bleul, A., Driesch, D., Ernst, G., and von Eggeling, F. (2004) Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technology. Int. J. Oncol. 24, 885-891
21. Gramantieri, L., Trere, D., Chieco, P., Lacchini, M., Giovannini, C., Piscaglia, F., Cavallari, A., and Bolondi, L. (2003) In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair. J. Hepatol. 39, 997-1003
22. Fujii, K., Kondo, T., Yokoo, H., Yamada, T., Iwatsuki, K., and Hirohashi, S. (2005) Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5, 1411-1422
23. Hu, T. H., Huang, C. C., Liu, L. F., Lin, P. R., Liu, S. Y., Chang, H. W., Changchien, C. S., Lee, C. M., Chuang, J. H., and Tai, M. H. (2003) Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Cancer 98, 1444-1456
24. Seow, T. K., Ong, S. E., Liang, R. C., Ren, E. C., Chan, L., Ou, K., and Chung, M. C. (2000) Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis 21, 1787-1813
25. Ou, K., Seow, T. K., Liang, R. C., Ong, S. E., and Chung, M. C. (2001) Proteome analysis of a human hepatocellular carcinoma cell line, HCC-M: an update. Electrophoresis 22, 2804-2811
26. Liang, R. C., Neo, J. C., Lo, S. L., Tan, G. S., Seow, T. K., and Chung, M. C. (2002) Proteome database of hepatocellular carcinoma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 771, 303-328
27. Cui, J. F., Liu, Y. K., Pan, B. S., Song, H. Y., Zhang, Y., Sun, R. X., Chen, J., Feng, J. T., Tang, Z. Y., Yu, Y. L., Shen, H. L., and Yang, P. Y. (2004) Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. J. Cancer Res. Clin. Oncol. 130, 615-622
28. Yang, Z. F., Ho, D. W., Lam, C. T., Luk, J. M., Lum, C. T., Yu, W. C., Poon, R. T., and Fan, S. T. (2005) Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res. 65, 219-225
29. Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F., Romano, P. R., Fimmel, C., Tennant, B. C., London, W. T., Evans, A. A., Blumberg, B. S., Dwek, R. A., Mattu, T. S., and Mehta, A. S. (2005) Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. U. S. A. 102, 779-784
30. Cui, F., Wang, Y., Wang, J., Wei, K., Hu, J., Liu, F., Wang, H., Zhao, X., Zhang, X., and Yang, X. (2006) The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice. Proteomics 6, 498-504
31. Ding, S. J., Li, Y., Tan, Y. X., Jiang, M. R., Tian, B., Liu, Y. K., Shao, X. X., Ye, S. L., Wu, J. R., Zeng, R., Wang, H. Y., Tang, Z. Y., and Xia, Q. C. (2004) From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell. Protemics 3, 73-81
32. Steel, L. F., Shumpert, D., Trotter, M., Seeholzer, S. H., Evans, A. A., London, W. T., Dwek, R., and Block, T. M. (2003) A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 3, 601-609
33. Wang, Z., Ruan, Y. B., and Guan, Y. (2003) Analysis of proteomic components of sera from patients with hepatocellular carcinomas by two-dimensional electrophoresis and matrix-assisted laser clesorption/ ionization time of flying mass spectrometry. Zhonghua Bing Li Xue Za Zhi 32, 333-336
34. Poon, T. C., Yip, T. T., Chan, A. T., Yip, C., Yip, V., Mok, T. S., Lee, C. C., Leung, T. W., Ho, S. K., and Johnson, P. J. (2003) Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepdtocellular carcinoma and its subtypes. Clin. Chem. 49, 752-760
35. Schwegler, E. E., Gazares, L., Steel, L. F., Adam, B. L., Johnson, D. A., Semmes, O. J., Block, T. M., Marrero, J. A., and Drake, R. R. (2005) SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 41, 634-642
36. Paradis, V., Degos, F., Dargere, D., Pham, N., Belghiti, J., Degott, C., Janeau, J. L., Bezeaud, A., Delforge, D., Cubizolles, M., Laurendeau, I., and Bedossa, P. (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41, 40-47
37. Le Naour, F., Brichory, F., Misek, D. E., Brechot, C., Hanash, S. M., and Beretta, L. (2002) A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol. Cell. Proteomics 1, 197-203
38. Comunale, M. A., Mattu, T. S., Lowman, M. A., Evans, A. A., London, W. T., Semmes, O. J., Ward, M., Drake, R., Romano, P. R., Steel, L. F., Block, T. M., and Mehta, A. (2004) Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics 4, 826-838
39. Xu, X. R., Huang, J., Xu, Z. G., Qian, B. Z., Zhu, Z. D., Yan, Q., Cai, T., Zhang, X., Xiao, H. S., Qu, J., Liu, F., Huang, Q. H., Cheng, Z. H., Li, N.G., Du, J. J., Hu, W., Shen, K. T., Lu, G., Fu, G., Zhong, M., Xu, S. H., Gu, W. Y., Huang, W., Zhao, X. T., Hu, G. X., Gu, J. R., Chen, Z., and Han, Z. G. (2001) Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci. U. S. A. 98, 15089-15094
40. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N., Toda, T., Sakaida, I., Okita, K., Oka, M., and Nakamura, K. (2003) Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 3, 2487-2493
41. Hu, J., and Seeger, C. (1996) Hsp9O is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 93, 1060-1064
42. Ballinger, C. A., Connell, P., Wu, Y., Hu, Z., Thompson, L. J., Yin, L. Y., and Patterson, C. (1999) Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell. Biol. 19, 4535-4545
43. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., and Lobley, A. (2004) The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 3, 311-326
44. Cuezva, J. M., Krajewska, M., de Heredia, M. L., Krajewski, S., Santamaria, G., Kim, H., Zapata, J. M., Marusawa, H., Chamorro, M., and Reed, J. C. (2002) The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 62, 6674-6681
45. Cuezva, J. M., Chen, G., Alonso, A. M., Isidoro, A., Misek, D. E., Hanash, S. M., and Beer, D. G. (2004) The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis 25, 1157-1163
46. Modica-Napolitano, J. S., and Singh, K. (2002) Mitochondria as targets for detection and treatment of cancer. Expert Rev. Mol. Med. 2002, 1-19
47. Chignard, N., and Beretta, L. (2004) Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology 127, S120-S125
48. Litwin, J. A., Beier, K., Volkl, A., Hofmann, W. J., and Fahimi, H. D. (1999) Immunocytochernical investigation of catalase and peroxisomal lipid beta-oxidation enzymes in human hepatocellular tumors and liver cirrhosis. Virchows Arch. 435, 486-495
49. Dreger, M. (2003) Subcellular proteomics. Mass Spectrom. Rev. 22, 27-56
50. Martinez-Chantar, M. L., Corrales, F. J., Martinez-Cruz, L. A., Garcia-Trevijano, E. R., Huang, Z. Z., Chen, L., Kanel, G., Avila, M. A., Mato, J. M., and Lu, S. C. (2002) Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 16, 1292-1294
51. Santamaria, E., Avila, M. A., Latasa, M. U., Rubio, A., Martin-Duce, A., Lu, S. C., Mato, J. M., and Corrales, F. J. (2003) Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc. Natl. Acad. Sci. U. S. A. 100, 3065-3070
52. Chen, Y. M., Shiu, J. Y., Tzeng, S. J., Shih, L. S., Chen, Y. J., Lui, W. Y., and Chen, P. H. (1998) Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int. J. Cancer 75, 787-793
53. Avila, M. A., Berasain, C., Torres, L., Martin-Duce, A., Corrales, F. J., Yang, H., Prieto, J., Lu, S. C., Caballeria, J., Rodes, J., and Mato, J. M. (2000) Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 33, 907-914
54. Yin, P. H., Lee, H. C., Chau, G. Y., Liu, T. Y., Liu, H. C., Lui, W. Y., and Chi, C. W. (2004) Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females. Cancer Lett. 212, 195-201
55. Epner, D. E., and Coffey, D. S. (1996) There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue. Prostate 28, 372-378
56. Gong, Y., Cui, L., and Minuk, G. Y. (11996) Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28s-ribosomal RNA gene expression in human hepatocellular carcinoma. Hepatology 23, 734-737
57. Altenberg, B., and Greulich, K. O. (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014-1020
58. Lapierre, P., Hajoui, O., Homberg, J. C., and Alvarez, F. (1999) Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 116, 643-649
59. Iizuka, N., Mori, N., Tamesa, T., Tangoku, A., and Oka, M. (2003) Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma. Anticancer Res. 23, 43-47
60. Ford, L. P., Wright, W. E., and Shay, J. W. (2002) A model for heterogeneous nuclear ribonucleoproteins in teiornere and telomerase regulation. Oncogene 21, 580-583
61. Kim, J. H., Paek, K. Y., Choi, K., Kim, T. D., Hahm, B., Kim, K. T., and Jang, S. K. (2003) Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol. Cell. Biol. 23, 708-720
62. Hossain, M. N., Fuji, M., Miki, K., Endoh, M., and Ayusawa, D. (2006) Downregulation of hnRNP C1/C2 by siRNA sensitizes HeLa cells to various stresses. Mol. Cell. Biochem. 296, 151-157
63. Shetty, S. (2005) Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells. Mol. Cell. Biochem. 272, 107-118
64. Ng, L. F., Chan, M., Chan, S. H., Chang, P. C., Leung, E. H., Chen, W. N., and Ran, E. C. (2005) Host heterogeneous ribonucleoprotein K (hnRNPK) as a potential target to suppress hepatitis B virus replication. PLoS Med. 2, e163
65. Honore, B., Baandrup, U., and Vorum, H. (2004) Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues. Exp. Cell Res. 294, 199-209
66. Choong, M. L., Tan, L. K., Lo, S. L., Ren, E. C., Ou, K., Ong, S. E., Liang, R. C., Seow, T. K., and Chung, M. C. (2001) An integrated approach in the discovery and characterization of a novel nuclear protein over-expressed in liver and pancreatic tumors. FEBS Lett. 496, 109-116
67. Chen, F., Kook, H., Milewski, R., Gitler, A. D., Lu, M. M., Li, J., Nazarian, R., Schnepp, R., Jen, K., Biben, C., Runke, G., Mackay, J. P., Novotny, J., Schwartz, R. J., Harvey, R. P., Mullins, M. C., and Epstein, J. A. (2002) Hop is an unusual homeobox gene that modulates cardiac development. Cell 110, 713-723
68. Shin, C. H., Liu, Z. P., Passier, R., Zhang, C. L., Wang, D. Z., Harris, T. M., Yamagishi, H., Richardson, J. A., Childs, G., and Olson, E. N. (2002) Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110, 725-735